Clinical trial

Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging

NCT02798484

Study summary

ClinicalTrials.gov

Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Diffusion-weighted Nuclear Magnetic Resonance Imaging (MRI) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-21

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Diffusion-weighted Nuclear Magnetic Resonance Imaging (MRI)DEVICE

Sponsors & collaborators

Brugmann University Hospitallead sponsor

Mapped research locations

BrusselsBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02798484 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.